Cell Isolation Market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $8.2 billion by 2028, growing at a CAGR of 13.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as rising cell-based research and increasing focus on personalized medicine are driving the growth of this market. However, high cost and safety, ethical issues, are the major factors restraining the growth of this market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479
The consumables segment accounted for the largest share of the product segment in the cell isolation market in 2022.
Based on product, the cell isolation market is broadly segmented into consumables, and instruments. In 2022, consumables accounted for the largest share of the cell isolation market for product. This segment’s large share can be attributed to factors such as the wide usage of reagents during cell isolation and continuous introduction of advanced consumables for cell isolation. Consumables can be used for a wide range of applications and cell types, making them a versatile choice for researchers. Some consumables, such as antibody-based cell isolation kits, are non-destructive and can isolate cells without damaging them, which is important for downstream applications. Consumables can be used to isolate large numbers of cells, which is important for applications such as cell therapy and drug discovery where large quantities of cells are needed.
The human cells segment accounted for the largest share of the cell type segment in the cell isolation market in 2022.
Based on cell type, the cell isolation market is categorized into two segments—human cells and animal cells. In 2022, human cells segment accounted for the largest share of cell isolation market. Factors such as the increasing investments by public and private organizations for research on human cells are projecting the segmental growth. The use of human cells for research is regulated by various agencies, such as the FDA and the NIH. Therefore, using human cells that have been obtained from reputable sources can ensure regulatory compliance. Human cells are directly relevant to clinical applications such as regenerative medicine, tissue engineering, and cell-based therapies. This makes human cell isolation an essential part of medical research. Human cells are diverse, which allows for the study of a wide range of diseases and conditions. Human cell isolation allows researchers to isolate specific cell types for further study.
Asia Pacific is likely to grow at double digit growth rate during the forecast period.
The Asia Pacific region is estimated to grow at the highest CAGR in the cell isolation market during the forecast period, this is mainly due to the rising geriatric population and increasing number of hospitals in Asian countries. Moreover, increasing chronic diseases in the countries of this region is likely to boost the market. Also, growing infectious diseases in the region is attracting several foreign investors in the market. Governments in the APAC region are supporting research in various ways, such as funding research institutes and offering tax incentives to biotech and life sciences companies. This has led to an increased demand for cell isolation technologies to support this research.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=103931479
Cell Isolation Market Dynamics:
- Increasing government funding for cell-based research
- Increasing number of patients suffering from cancer and infectious diseases
- Technological advancements
- Growing focus on personalized medicine
- Ethical issues related to embryonic stem cell isolation
- High cost of cell-based research
- Emerging markets
Key Market Players:
Some of the prominent players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=103931479
- In October 2022, Thermo Fisher Scientific, Inc. launched DynaCellect, a next-generation cell isolation, cell activation, cell depletion instrument. It also launched the Dynabeads magnetic beads removal instrument to optimize the cell therapy manufacturing process.
- In June 2022, Terumo BCT and GenCure collaborated to advance cell and gene therapy manufacturing solutions.
- In May 2022, Terumo BCT inaugurated its second manufacturing facility in Colorado.
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Address:630 Dundee Road Suite 430
State: IL 60062
Country: United States